Skip to main content

Advertisement

SpringerLink
Log in

Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent

  • Biotechnologically relevant enzymes and proteins
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

L-asparaginase has been used in the treatment of patients with acute lymphoblastic leukemia (ALL) for more than 30 years. Rapid clearance of the enzyme from blood stream and its L-glutaminase-dependent neurotoxicity has led to searching for new L-asparaginases with more desirable properties. In the present study, L-asparaginase coding gene of Halomonas elongata was isolated, expressed in Escherichia coli, purified, and characterized. The purified protein was found to have a molecular mass of 39.5 kDa and 1000-folds more activity towards L-asparagine than L-glutamine. Enzyme-specific activity towards L-asparagine was determined to be 1510 U/mg, which is among the highest reported values for microbial L-asparaginases. K m , Vmax, and k cat values were 5.6 mM, 2.2 μmol/min, and 1.96 × 103 1/S, respectively. Optimum temperature was found to be 37 °C while the enzyme showed maximum activity at a wide pH range (from 6 to 9). Enzyme half-life in the presence of human serum at 37 °C was 90 min which is three times higher when compared with reported values for E. coli L-asparaginase. Enzyme showed cytotoxic effects against Jurkat and U937 cell lines with an IC50 of 2 and 1 U/ml, respectively. Also, no toxic effects on human erythrocytes and Chinese hamster ovary cell lines were detected, and just minor inhibitory effects on human umbilical vein endothelial cells were observed. This is the first report describing the therapeutic potentials of a recombinant L-asparaginase isolated from a halophilic bacterium as an anticancer agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Notes

  1. Mean amino acid residue weight

References

  • Aalberse RC, Akkerdaas J, van Ree R (2001) Cross-reactivity of IgE antibodies to allergens. Allergy 56(6):478–490

    Article  CAS  PubMed  Google Scholar 

  • Agrawal V, Woo JH, Borthakur G, Kantarjian H, Frankel AE (2013) Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia. Protein Pept Lett 20(4):392–402

    CAS  PubMed  Google Scholar 

  • Amin K, Dannenfelser RM (2006) In vitro hemolysis: guidance for the pharmaceutical scientist. J Pharm Sci 95(6):1173–1176. doi:10.1002/jps.20627

    Article  CAS  PubMed  Google Scholar 

  • Andrade AF, Borges KS, Silveira VS (2014) Update on the use of l-Asparaginase in infants and adolescent patients with acute lymphoblastic leukemia. Clin Med Insights Oncol 8:95–100. doi:10.4137/CMO.S10242

    PubMed  PubMed Central  Google Scholar 

  • Arif HMHZ (2014) Important sources and medicinal applications of L-asparaginase. Int J Pharma Res Rev 3(6):35–45

    CAS  Google Scholar 

  • Asad S, Khajeh K, Ghaemi N (2011) Investigating the structural and functional effects of mutating Asn glycosylation sites of horseradish peroxidase to asp. Appl Biochem Biotechnol 164(4):454–463. doi:10.1007/s12010-010-9147-1

    Article  CAS  PubMed  Google Scholar 

  • Asad S, Dastgheib SMM, Khajeh K (2015) Construction of a horseradish peroxidase resistant toward hydrogen peroxide by saturation mutagenesis. Biotechnol Appl Bioc 63(6):789–794

    Article  Google Scholar 

  • Asselin BL, Whitin JC, Coppola DJ, Rupp IP, Sallan SE, Cohen HJ (1993) Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol 11(9):1780–1786. doi:10.1200/jco.1993.11.9.1780

    Article  CAS  PubMed  Google Scholar 

  • Avramis VI, Sencer S, Periclou AP, Sather H, Bostrom BC, Cohen LJ, Ettinger AG, Ettinger LJ, Franklin J, Gaynon PS, Hilden JM, Lange B, Majlessipour F, Mathew P, Needle M, Neglia J, Reaman G, Holcenberg JS, Stork L (2002) A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's cancer group study. Blood 99(6):1986–1994

    Article  CAS  PubMed  Google Scholar 

  • Babavalian H, Amoozegar MA, Zahraei S, Rohban R, Shakeri F, Moghaddam MM (2014) Comparison of bacterial biodiversity and enzyme production in three Hypersaline Lakes; Urmia, Howz-Soltan and Aran-Bidgol. Indian J Microbiol 54(4):444–449. doi:10.1007/s12088-014-0481-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bansal S, Gnaneswari D, Mishra P, Kundu B (2010) Structural stability and functional analysis of L-asparaginase from Pyrococcus furiosus. Biochemistry Mosc 75(3):375–381

    Article  CAS  PubMed  Google Scholar 

  • Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72(1):248–254. doi:10.1016/0003-2697(76)90527-3

    Article  CAS  PubMed  Google Scholar 

  • Broome JD (1963) Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance J Exp Med 118:99–120

    CAS  PubMed  Google Scholar 

  • Broome JD (1965) Antilymphoma activity of L-asparaginase in vivo: clearance rates of enzyme preparations from guinea pig serum and yeast in relation to their effect on tumor growth. J Natl Cancer Inst 35(6):967–974

    CAS  PubMed  Google Scholar 

  • Campbell HA, Mashburn LT (1969) L-Asparaginase EC-2 from Escherichia coli. Some substrate specificity characteristics. Biochemistry 8(9):3768–3775

    Article  CAS  PubMed  Google Scholar 

  • Cappelletti D, Chiarelli LR, Pasquetto MV, Stivala S, Valentini G, Scotti C (2008) Helicobacter pylori L-asparaginase: a promising chemotherapeutic agent. Biochem Biophys Res Commun 377(4):1222–1226. doi:10.1016/j.bbrc.2008.10.118

    Article  CAS  PubMed  Google Scholar 

  • Chan WK, Lorenzi PL, Anishkin A, Purwaha P, Rogers DM, Sukharev S, Rempe SB, Weinstein JN (2014) The glutaminase activity of l-asparaginase is not required for anticancer activity against ASNS-negative cells. Blood 123(23):3596–3606. doi:10.1182/blood-2013-10-535112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Choi J, Reipa V, Hitchins VM, Goering PL, Malinauskas RA (2011) Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci 123(1):133–143. doi:10.1093/toxsci/kfr149

    Article  CAS  PubMed  Google Scholar 

  • Clavell LA, Gelber RD, Cohen HJ, Hitchcock-Bryan S, Cassady JR, Tarbell NJ, Blattner SR, Tantravahi R, Leavitt P, Sallan SE (1986) Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med 315(11):657–663. doi:10.1056/nejm198609113151101

    Article  CAS  PubMed  Google Scholar 

  • Covini D, Tardito S, Bussolati O, Chiarelli LR, Pasquetto MV, Digilio R, Valentini G, Scotti C (2012) Expanding targets for a metabolic therapy of cancer: L-asparaginase. Recent Pat Anticancer Drug Discov 7(1):4–13

    Article  CAS  PubMed  Google Scholar 

  • de Lourdes Moreno M, Pérez D, García M, Mellado E (2013) Halophilic bacteria as a source of novel hydrolytic enzymes. Life 3(1):38

    Article  PubMed  PubMed Central  Google Scholar 

  • Distasio JA, Salazar AM, Nadji M, Durden DL (1982) Glutaminase-free asparaginase from vibrio succinogenes: an antilymphoma enzyme lacking hepatotoxicity. Int J Cancer 30(3):343–347

    Article  CAS  PubMed  Google Scholar 

  • Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E, Otten J, Philippe N (2002) Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's leukemia group phase 3 trial. Blood 99(8):2734–2739

    Article  CAS  PubMed  Google Scholar 

  • El-Bessoumy AA, Sarhan M, Mansour J (2004) Production, isolation, and purification of L-asparaginase from Pseudomonas aeruginosa 50071 using solid-state fermentation. J Biochem Mol Biol 37(4):387–393

    CAS  PubMed  Google Scholar 

  • El-Naggar NE-A, El-Ewasy SM, El-Shweihy NM (2014) Microbial L-asparaginase as a potential therapeutic agent for the treatment of acute lymphoblastic leukemia: the pros and cons. Int J Pharm 10:182–199

  • Ertel IJ, Nesbit ME, Hammond D, Weiner J, Sather H (1979) Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens cancer study group. Cancer Res 39(10):3893–3896

    CAS  PubMed  Google Scholar 

  • Eslami M, Amoozegar MA, Asad S (2016) Isolation, cloning and characterization of an azoreductase from the halophilic bacterium Halomonas elongata. Int J Biol Macromolec 85:111–116. doi:10.1016/j.ijbiomac.2015.12.065

    Article  CAS  Google Scholar 

  • Fu CH, Sakamoto KM (2007) PEG-asparaginase. Expert Opin Pharmacother 8(12):1977–1984. doi:10.1517/14656566.8.12.1977

    Article  CAS  PubMed  Google Scholar 

  • Han S, Jung J, Park W (2014) Biochemical characterization of L-asparaginase in NaCl-tolerant Staphylococcus sp. OJ82 isolated from fermented seafood. J Microbiol Biotechnol 24(8):1096–1104

    Article  CAS  PubMed  Google Scholar 

  • Henikoff S, Henikoff JG (1992) Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A 89(22):10915–10919

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hill JM, Roberts J, Loeb E, Khan A, MacLellan A, Hill RW (1967) L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA 202(9):882–888

    Article  CAS  PubMed  Google Scholar 

  • Husain I, Sharma A, Kumar S, Malik F (2016a) Purification and characterization of Glutaminase free Asparaginase from Enterobacter cloacae: in-vitro evaluation of cytotoxic potential against human myeloid leukemia HL-60 cells. PLoS One 11(2):e0148877. doi:10.1371/journal.pone.0148877

    Article  PubMed  PubMed Central  Google Scholar 

  • Husain I, Sharma A, Kumar S, Malik F (2016b) Purification and characterization of glutaminase free asparaginase from Pseudomonas otitidis: induce apoptosis in human leukemia MOLT-4 cells. Biochimie 121:38–51. doi:10.1016/j.biochi.2015.11.012

    Article  CAS  PubMed  Google Scholar 

  • Kabiri M, Oraee-Yazdani S, Dodel M, Hanaee-Ahvaz H, Soudi S, Seyedjafari E, Salehi M, Soleimani M (2015) Cytocompatibility of a conductive nanofibrous carbon nanotube/poly (L-lactic acid) composite scaffold intended for nerve tissue engineering. EXCLI journal 14:851–860. doi:10.17179/excli2015-282

    PubMed  PubMed Central  Google Scholar 

  • Kanazawa S, Kiyota H (1995) Estimation of L-glutaminase and L-asparaginase activities in soils by the indophenol method. Soil Sci Plant Nutr 41(2):305–311. doi:10.1080/00380768.1995.10419587

    Article  CAS  Google Scholar 

  • Khushoo A, Pal Y, Singh BN, Mukherjee KJ (2004) Extracellular expression and single step purification of recombinant Escherichia coli L-asparaginase II. Protein Expr Purif 38(1):29–36. doi:10.1016/j.pep.2004.07.009

    Article  CAS  PubMed  Google Scholar 

  • Kidd JG (1953) Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum. J Exp Med 98(6):565–582

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Killander D, Dohlwitz A, Engstedt L, Franzen S, Gahrton G, Gullbring B, Holm G, Holmgren A, Hoglund S, Killander A, Lockner D, Mellstedt H, Moe PJ, Palmblad J, Reizenstein P, Skarberg KO, Swedberg B, Uden AM, Wadman B, Wide L, Ahstrom L (1976) Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia. Cancer 37(1):220–228

    Article  CAS  PubMed  Google Scholar 

  • Kishore V, Nishita KP, Manonmani HK (2015) Cloning, expression and characterization of l-asparaginase from Pseudomonas fluorescens for large scale production in E. coli BL21. 3. Biotech 5(6):975–981. doi:10.1007/s13205-015-0300-y

    Google Scholar 

  • Korver K, Boeschoten EW, Krediet RT, van Steenis G, Schellekens PT (1987) Dose-response effects in immunizations with keyhole limpet haemocyanin and rabies vaccine: shift in some immunodeficiency states. Clin Exp Immunol 70(2):328–335

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kumar S, Veeranki VD, Pakshirajan K (2011a) Assessment of physical process conditions for enhanced production of novel glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428. Appl Biochem Biotechnol 163(3):327–337. doi:10.1007/s12010-010-9041-x

    Article  CAS  PubMed  Google Scholar 

  • Kumar S, Venkata Dasu V, Pakshirajan K (2011b) Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428. Bioresour Technol 102(2):2077–2082. doi:10.1016/j.biortech.2010.07.114

    Article  CAS  PubMed  Google Scholar 

  • Larson RA, Fretzin MH, Dodge RK, Schiffer CA (1998) Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia. Leukemia 12(5):660–665

    Article  CAS  PubMed  Google Scholar 

  • Lee SJ, Lee Y, Park GH, Umasuthan N, Heo SJ, De Zoysa M, Jung WK, Lee DW, Kim H, Kang DH, Oh C (2016) A newly identified Glutaminase-free L-Asparaginase (L-ASPG86) from the marine bacterium Mesoflavibacter zeaxanthinifaciens. J Microbiol Biotechnol 26(6):1115–1123. doi:10.4014/jmb.1510.10092

    Article  PubMed  Google Scholar 

  • Mahajan RV, Kumar V, Rajendran V, Saran S, Ghosh PC, Saxena RK (2014) Purification and characterization of a novel and robust L-asparaginase having low-glutaminase activity from Bacillus licheniformis: in vitro evaluation of anti-cancerous properties. PLoS One 9(6):e99037. doi:10.1371/journal.pone.0099037

    Article  PubMed  PubMed Central  Google Scholar 

  • Meena B, Anburajan L, Dheenan PS, Begum M, Vinithkumar NV, Dharani G, Kirubagaran R (2015) Novel glutaminase free L-asparaginase from Nocardiopsis alba NIOT-VKMA08: production, optimization, functional and molecular characterization. Bioprocess Biosyst Eng 38(2):373–388. doi:10.1007/s00449-014-1277-3

    Article  CAS  PubMed  Google Scholar 

  • Mesbah NM, Wiegel J (2014) Purification and biochemical characterization of halophilic, alkalithermophilic protease AbCP from Alkalibacillus sp. NM-Fa4. J Mol Catal 105:74–81. doi:10.1016/j.molcatb.2014.03.023

    Article  CAS  Google Scholar 

  • Mohammadnejad L, Baradaran B, Shanehbandi D, Pourhassan Moghaddam M, Sadreddini S (2013) Cloning and expression of human L- Asparaginase and study of its anti growth effect on leukemia cell lines. Front Imm. doi:10.3389/conf.fimmu.2013.02.00192

  • Muller HJ, Beier R, Loning L, Blutters-Sawatzki R, Dorffel W, Maass E, Muller-Weihrich S, Scheel-Walter HG, Scherer F, Stahnke K, Schrappe M, Horn A, Lumkemann K, Boos J (2001) Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment. Br J Haematol 114(4):794–799

    Article  CAS  PubMed  Google Scholar 

  • Narta UK, Kanwar SS, Azmi W (2007) Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit Rev Oncol Hematol 61(3):208–221. doi:10.1016/j.critrevonc.2006.07.009

    Article  PubMed  Google Scholar 

  • Needleman SB, Wunsch CD (1970) A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol 48(3):443–453

    Article  CAS  PubMed  Google Scholar 

  • Oettgen HF, Old LJ, Boyse EA, Campbell HA, Philips FS, Clarkson BD, Tallal L, Leeper RD, Schwartz MK, Kim JH (1967) Inhibition of leukemias in man by L-asparaginase. Cancer Res 27(12):2619–2631

    CAS  PubMed  Google Scholar 

  • Oettgen HF, Stephenson PA, Schwartz MK, Leeper RD, Tallai L, Tan CC, Clarkson BD, Golbey RB, Krakoff IH, Karnofsky DA, Murphy ML, Burchenal JH (1970) Toxicity of E. coli L-asparaginase in man. Cancer 25(2):253–278

    Article  CAS  PubMed  Google Scholar 

  • Ohnuma T, Bergel F, Bray RC (1967) Enzymes in cancer. Asparaginase from chicken liver. Biochem J 103(1):238–245

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Oza VP, Parmar PP, Patel DH, Subramanian RB (2011) Cloning, expression and characterization of l-asparaginase from Withania somnifera L. for large scale production. 3. Biotech 1(1):21–26. doi:10.1007/s13205-011-0003-y

    Google Scholar 

  • Panosyan EH, Grigoryan RS, Avramis IA, Seibel NL, Gaynon PS, Siegel SE, Fingert HJ, Avramis VI (2004a) Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961). Anticancer Res 24(2C):1121–1125

    CAS  PubMed  Google Scholar 

  • Panosyan EH, Seibel NL, Martin-Aragon S, Gaynon PS, Avramis IA, Sather H, Franklin J, Nachman J, Ettinger LJ, La M, Steinherz P, Cohen LJ, Siegel SE, Avramis VI (2004b) Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children’s cancer group study CCG-1961. J Pediatr Hematol Oncol 26(4):217–226

    Article  PubMed  Google Scholar 

  • Park YK, Abuchowski A, Davis S, Davis F (1981) Pharmacology of Escherichia Coli-L-asparaginase polyethylene glycol adduct. Anticancer Res 1(6):373–376

  • Paul WE, Siskind GW, Benacerraf B (1968) Specificity of cellular immune responses. Antigen concentration dependence of stimulation of DNA synthesis in vitro by specifically sensitized cells, as an expression of the binding characteristics of cellular antibody. J Exp Med 127(1):25–42

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pourhossein M, Korbekandi H (2014) Cloning, expression, purification and characterisation of Erwinia carotovora L-asparaginase in Escherichia Coli. Adv Biomed Res 3:82. doi:10.4103/2277-9175.127995

  • Pritsa AA, Kyriakidis DA (2001) L-asparaginase of Thermus thermophilus: purification, properties and identification of essential amino acids for its catalytic activity. Mol Cell Biochem 216(1–2):93–101

    Article  CAS  PubMed  Google Scholar 

  • Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV (2009) Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360(26):2730–2741. doi:10.1056/NEJMoa0900386

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ramakrishnan MS, Joseph R (1996) Characterization of an extracellular asparaginase of Rhodosporidium toruloides CBS14 exhibiting unique physicochemical properties. Can J Microbiol 42(4):316–325. doi:10.1139/m96-047

    Article  CAS  Google Scholar 

  • Rati Sinha HS, Jha SK (2013) Microbial L-asparaginase: present and future prospective. IJIRSET 2(11):7031–7051

    Google Scholar 

  • Sallan SE, Hitchcock-Bryan S, Gelber R, Cassady JR, Frei E 3rd, Nathan DG (1983) Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res 43(11):5601–5607

    CAS  PubMed  Google Scholar 

  • Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York

  • Shirazian P, Asad S, Amoozegar MA (2016) The potential of halophilic and halotolerant bacteria for the production of antineoplastic enzymes: L-asparaginase and L-glutaminase. EXCLI J 15:268–279. doi:10.17179/excli2016-146

    PubMed  PubMed Central  Google Scholar 

  • Shivanand PMG (2015) Halophilic bacteria and their compatible solutes – osmoregulation and potential applications. Cur Sci India 100(10):1516–1521

    Google Scholar 

  • Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Arkin S, Declerck L, Cohen HJ, Sallan SE (2001) Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber consortium protocol 91-01. Blood 97(5):1211–1218

    Article  CAS  PubMed  Google Scholar 

  • Soares AL, Guimaraes GM, Polakiewicz B, de Moraes Pitombo RN, Abrahao-Neto J (2002) Effects of polyethylene glycol attachment on physicochemical and biological stability of E. coli L-asparaginase. Int J Pharm 237(1–2):163–170

    Article  CAS  PubMed  Google Scholar 

  • Tan SC, Yiap BC (2009) DNA, RNA, and protein extraction: the past and the present. J Biomed Biotechnol 2009:574398. doi:10.1155/2009/574398

    Article  PubMed  PubMed Central  Google Scholar 

  • Vrooman LM, Supko JG, Neuberg DS, Asselin BL, Athale UH, Clavell L, Kelly KM, Laverdiere C, Michon B, Schorin M, Cohen HJ, Sallan SE, Silverman LB (2010) Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 54(2):199–205. doi:10.1002/pbc.22225

    PubMed  PubMed Central  Google Scholar 

  • Wang B, Relling MV, Storm MC, Woo MH, Ribeiro R, Pui CH, Hak LJ (2003) Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. Leukemia 17(8):1583–1588. doi:10.1038/sj.leu.2403011

    Article  CAS  PubMed  Google Scholar 

  • Warrell RP, Chou T-C, Gordon C, Tan C, Roberts J, Sternberg SS, Philips FS, Young CW (1980) Phase I evaluation of Succinylated Acinetobacter Glutaminase-Asparaginase in adults. Cancer Res 40(12):4546–4551

    PubMed  Google Scholar 

  • Warrell RP Jr, Arlin ZA, Gee TS, Chou TC, Roberts J, Young CW (1982) Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia. Cancer Treat Rep 66(7):1479–1485

  • Werber G, Ahlke E, Nowak-Göttl U, Jürgens H, Verspohl EJ, Boos J (1997) Asparaginase activities In Vitro are highly sensitive to different buffer conditions. In: Büchner T, Schellong G, Ritter J, Creutzig U, Hiddemann W, Wörmann B (eds) Acute Leukemias VI: prognostic factors and treatment strategies. Springer, Berlin Heidelberg, Berlin, Heidelberg, pp 512–516

    Chapter  Google Scholar 

  • Willer A, Gerss J, Konig T, Franke D, Kuhnel HJ, Henze G, von Stackelberg A, Moricke A, Schrappe M, Boos J, Lanvers-Kaminsky C (2011) Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials. Blood 118(22):5774–5782. doi:10.1182/blood-2011-07-367904

    Article  CAS  PubMed  Google Scholar 

  • Woo MH, Hak LJ, Storm MC, Sandlund JT, Ribeiro RC, Rivera GK, Rubnitz JE, Harrison PL, Wang B, Evans WE, Pui CH, Relling MV (2000) Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 18(7):1525–1532

    Article  CAS  PubMed  Google Scholar 

  • Yoshimoto T, Nishimura H, Saito Y, Sakurai K, Kamisaki Y, Wada H, Sako M, Tsujino G, Inada Y (1986) Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia. Jpn J Cancer Res 77(12):1264–1270

    CAS  PubMed  Google Scholar 

  • Young CR, Ebringer A, Archer JR (1978) Antigen dose and strain variation as factors in the genetic control of the immune response to sperm whale myoglobin. Immunology 34(3):571–579

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to thank the research council of the University of Tehran for the financial support of this research.

Author information

Authors and Affiliations

  1. Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran

    Ali Ghasemi, Sedigheh Asad & Mahboubeh Kabiri

  2. Department of Biochemistry, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran

    Bahareh Dabirmanesh

Authors
  1. Ali Ghasemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sedigheh Asad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahboubeh Kabiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bahareh Dabirmanesh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sedigheh Asad.

Ethics declarations

There is no conflict of interest and no benefit of any kind will be received either directly or indirectly by the authors.

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghasemi, A., Asad, S., Kabiri, M. et al. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent. Appl Microbiol Biotechnol 101, 7227–7238 (2017). https://doi.org/10.1007/s00253-017-8456-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-017-8456-5

Keywords

Search

Navigation